Paris Offor joined Immuneering as a Senior Research Associate in July 2026 with over five years of experience in in-vitro pharmacology, translational cancer research, and preclinical drug development. She has contributed to numerous preclinical oncology studies in the past by applying expertise in both advanced mammalian and patient-derived xenograft (PDX) cell culture, flow cytometry, high-content imaging, and molecular biology techniques. Paris has a strong foundation in experimental design, data analysis, and supporting the advancement of novel cancer therapeutics. Ms Offor earned a B.S. in Public Health from San Diego State University.